Tompkins Financial Corp Gilead Sciences, Inc. Transaction History

Tompkins Financial Corp

$1.04 Billion
Q3 2024

A detailed history of Tompkins Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tompkins Financial Corp holds 1,994 shares of GILD stock, worth $179,838. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,994

Previous 1,917 4.02%

Holding current value

$179,838

Previous $131,000 27.48%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$66.59 - $83.99 $5,127 - $6,467	77 Added 4.02%	1,994 $167,000
Q2 2024 Jul 17, 2024	SELL	$63.15 - $72.88 $1,894 - $2,186	-30 Reduced 1.54%	1,917 $131,000
Q1 2024 Apr 08, 2024	BUY	$71.58 - $87.29 $501 - $611	7 Added 0.36%	1,947 $142,000
Q4 2023 Jan 08, 2024	BUY	$73.27 - $83.09 $116,572 - $132,196	1,591 Added 455.87%	1,940 $157,000
Q3 2023 Nov 20, 2023	BUY	$73.94 - $80.67 $17,819 - $19,441	241 Added 223.15%	349 $26,000
Q4 2022 Jan 06, 2023	BUY	$62.32 - $89.47 $4,985 - $7,157	80 Added 285.71%	108 $9,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $5,212 - $6,532	-90 Reduced 76.27%	28 $2,000
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $25,952 - $29,456	-400 Reduced 77.22%	118 $9,000
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $67 - $73	-1 Reduced 0.19%	518 $36,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $5.33 Million - $6.07 Million	-94,024 Reduced 99.45%	519 $30,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $5.3 Million - $6.04 Million	93,605 Added 9979.21%	94,543 $7.07 Million
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 9.63%	938 $59,000
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $6,638 - $8,503	-106 Reduced 9.27%	1,038 $78,000
Q4 2019 Jan 22, 2020	BUY	$61.62 - $67.78 $63,468 - $69,813	1,030 Added 903.51%	1,144 $74,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $10,126 - $11,178	-162 Reduced 58.7%	114 $7,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $52,836 - $59,250	-854 Reduced 75.58%	276 $19,000
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $903,933 - $1.01 Million	-14,456 Reduced 92.75%	1,130 $73,000
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $31,327 - $35,095	-501 Reduced 3.11%	15,586 $1.2 Million
Q4 2018 Jan 22, 2019	BUY	$60.54 - $79.0 $30,330 - $39,579	501 Added 3.21%	16,087 $1.01 Million
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $7,626 - $8,444	107 Added 0.69%	15,586 $1.2 Million
Q2 2018 Jul 18, 2018	BUY	$64.88 - $75.68 $42,236 - $49,267	651 Added 4.39%	15,479 $1.1 Million
Q1 2018 Apr 26, 2018	BUY	$72.84 - $88.8 $251,516 - $306,626	3,453 Added 30.36%	14,828 $1.12 Million
Q4 2017 Jan 24, 2018	SELL	$71.15 - $83.52 $19,993 - $23,469	-281 Reduced 2.41%	11,375 $815,000
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $840,514 - $996,238	11,656	11,656 $944,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Gilead Sciences, Inc. Transaction History